RGNX CIK: 1590877

REGENXBIO Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
419
FY22:
58.2
FY23:
53.0
FY24:
49.8
FY25:
150
(positive)
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
−263
FY23:
−268
FY24:
−233
FY25:
−161
(positive)
Change from FY21 to FY25
millions USD
FY21:
170
FY22:
−250
FY23:
−251
FY24:
–
FY25:
−146
(positive)
Change from FY21 to FY25
millions USD
FY21:
141
FY22:
−280
FY23:
−264
FY24:
−227
FY25:
−194
(positive)
Change from FY21 to FY25
millions USD
FY21:
128
FY22:
−280
FY23:
−263
FY24:
−227
FY25:
−194

All amounts in millions USD Data sources:SEC EDGARTwelve Data